Literature DB >> 17290074

Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?

Emilio Bria, Massimo Di Maio, Federica Cuppone, Cecilia Nisticò, Francesco Cognetti, Diana Giannarelli.   

Abstract

Mesh：

Year:  2007        PMID： 17290074     DOI： 10.1200/JCO.2006.09.0365

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer.

Authors:  Y-H Gao; X Zhang; X An; M-Y Cai; Z-F Zeng; G Chen; L-H Kong; J-Z Lin; D-S Wan; Z-Z Pan; P-R Ding
Journal:  Strahlenther Onkol       Date:  2014-01-11       Impact factor: 3.621

Review 2.  First-Line Treatments for Poor-Prognosis Metastatic Renal Cell Carcinoma: Experts' Prescribing Practices and Systematic Literature Review.

Authors:  Olivia Le Saux; Gilles Freyer; Sylvie Négrier
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 2.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.